Synthesis of Deuterium-Labeled Vitamin D Metabolites as Internal Standards for LC-MS Analysis
Authors:
- Akiko NagataANAkiko Nagata
- Kazuto IijimaKIKazuto Iijima
- Ryota SakamotoRSRyota Sakamoto
- Yuka MizumotoYMYuka Mizumoto
- Miho IwakiMIMiho Iwaki
- Masaki TakiwakiMTMasaki Takiwaki
- Yoshikuni KikutaniYKYoshikuni Kikutani
- Seketsu FukuzawaSFSeketsu Fukuzawa
- Minami OdagiMOMinami Odagi
- Masayuki TeraMTMasayuki Tera
- Kazuo NagasawaKNKazuo Nagasawa
Open Access
Abstract
Blood levels of the vitamin D3 (D3) metabolites 25-hydroxyvitamin D3 (25(OH)D3), 24R,25-dihydroxyvitamin D3, and 1α,25-dihydroxyvitamin D3 (1,25(OH)2D3) are recognized indicators for the diagnosis of bone metabolism-related diseases, D3 deficiency-related diseases, and hypercalcemia, and are generally measured by liquid-chromatography tandem mass spectrometry (LC-MS/MS) using an isotope dilution method. However, other D3 metabolites, such as 20-hydroxyvitamin D3 and lactone D3, also show interesting biological activities and stable isotope-labeled derivatives are required for LC-MS/MS analysis of their concentrations in serum. Here, we describe a versatile synthesis of deuterium-labeled D3 metabolites using A-ring synthons containing three deuterium atoms. Deuterium-labeled 25(OH)D3 (2), 25(OH)D3-23,26-lactone (6), and 1,25(OH)2D3-23,26-lactone (7) were synthesized, and successfully applied as internal standards for the measurement of these compounds in pooled human serum. This is the first quantification of 1,25(OH)2D3-23,26-lactone (7) in human serum.Keywords
Funding Information
- Japan Agency for Medical Research and Development (###)
This publication has 37 references indexed in Scilit:
- Studies directed towards the total synthesis of koshikalide: stereoselective synthesis of the macrocyclic coreTetrahedron: Asymmetry, 2013
- Chemical synthesis of 20S-hydroxyvitamin D3, which shows antiproliferative activitySteroids, 2010
- Products of Vitamin D3 or 7-Dehydrocholesterol Metabolism by Cytochrome P450scc Show Anti-Leukemia Effects, Having Low or Absent Calcemic ActivityPLOS ONE, 2010
- 20,23‐dihydroxyvitamin D3, novel P450scc product, stimulates differentiation and inhibits proliferation and NF‐κB activity in human keratinocytesJournal of Cellular Physiology, 2009
- 20-Hydroxycholecalciferol, Product of Vitamin D3 Hydroxylation by P450scc, Decreases NF-κB Activity by Increasing IκBα Levels in Human KeratinocytesPLOS ONE, 2009
- Synthesis of 25-Hydroxyvitamin D3 and 26,26,26,27,27,27-Hexadeutero-25-hydroxyvitamin D3 on Solid SupportThe Journal of Organic Chemistry, 2009
- Vitamin D Status: Measurement, Interpretation, and Clinical ApplicationAnnals of Epidemiology, 2009
- Total synthesis of (+)-phorboxazole A, a potent cytostatic agent from the sponge Phorbas sp.Organic & Biomolecular Chemistry, 2003
- The difference of biological activity among four diastereoisomers of 1α,25-dihydroxycholecalciferol-26,23-lactoneThe Journal of Steroid Biochemistry and Molecular Biology, 1986
- The unique action for bone metabolism of 1α,25-(OH)2D3-26,23-lactoneBiochemical and Biophysical Research Communications, 1985